Hindsight 2020: Emerging research trends in schizophrenia

Association of Psychiatric Disorders With Mortality Among Patients With COVID-19

(2021) Katlyn Nemani et al.   JAMA Psychiatry

Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing

(2020) Jonghee Hong et al.   Clinical Psychopharmacology and Neuroscience

A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

(2020) Kenneth S. Koblan et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19, mobile health and serious mental illness

(2020) John Torous et al.   SCHIZOPHRENIA RESEARCH

The “mind” behind the “mask”: Assessing mental states and creating therapeutic alliance amidst COVID-19

(2020) Urvakhsh Meherwan Mehta et al.   SCHIZOPHRENIA RESEARCH

The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research

(2020) Ellie Brown et al.   SCHIZOPHRENIA RESEARCH

Models Predicting Psychosis in Patients With High Clinical Risk: A Systematic Review

(2020) Cristiana Montemagni et al.   Frontiers in Psychiatry

Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia

(2020) Brian Dean et al.   PSYCHIATRY RESEARCH

Unmask the mind! Importance of video consultations in psychiatry during COVID-19 pandemic

(2020) Jagadisha Thirthalli et al.   SCHIZOPHRENIA RESEARCH

Clinical and functional long-term outcome of patients at clinical high risk (CHR) for psychosis without transition to psychosis: A systematic review

(2019) Katharina Beck et al.   SCHIZOPHRENIA RESEARCH

A Genetics Perspective on the Role of the (Neuro)Immune System in Schizophrenia

(2019) Rebecca Birnbaum et al.   SCHIZOPHRENIA RESEARCH

Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist

(2019) Henry A. Nasrallah et al.   SCHIZOPHRENIA RESEARCH

Adjunctive memantine for major mental disorders: A systematic review and meta-analysis of randomized double-blind controlled trials

(2019) Wei Zheng et al.   SCHIZOPHRENIA RESEARCH

Identifying schizophrenia subgroups using clustering and supervised learning

(2019) Alexandra Talpalaru et al.   SCHIZOPHRENIA RESEARCH

Reduced connectivity in anterior cingulate cortex as an early predictor for treatment response in drug-naive, first-episode schizophrenia: A global-brain functional connectivity analysis

(2019) Huabing Li et al.   SCHIZOPHRENIA RESEARCH

The effect of minocycline on amelioration of cognitive deficits and pro-inflammatory cytokines levels in patients with schizophrenia

(2019) Lulu Zhang et al.   SCHIZOPHRENIA RESEARCH

Distinct striatum pathways connected to salience network predict symptoms improvement and resilient functioning in schizophrenia following risperidone monotherapy

(2019) Shaoqiang Han et al.   SCHIZOPHRENIA RESEARCH

Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies

(2019) Christina Wenneberg et al.   SCHIZOPHRENIA RESEARCH

Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP)

(2018) Suraj Sarvode Mothi et al.   SCHIZOPHRENIA RESEARCH

Improving individual predictions: Machine learning approaches for detecting and attacking heterogeneity in schizophrenia (and other psychiatric diseases)

(2017) Hugo G. Schnack   SCHIZOPHRENIA RESEARCH

Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study

(2017) Julie L. Winterburn et al.   SCHIZOPHRENIA RESEARCH

Schizophrenia risk from complex variation of complement component 4

(2016) Aswin Sekar et al.   NATURE